← FDA DRUG APPROVALS

FDA ANDA · ANDA077152

TERBUTALINE SULFATE

Sponsor: LANNETT CO INC

APPLICATION
ANDA077152
TYPE
ANDA
ORIGINAL APPROVAL
2005-03-25
LATEST ACTION
2011-04-08
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

TERBUTALINE SULFATEPrescription
TERBUTALINE SULFATE 5MG · TABLET · ORAL
TERBUTALINE SULFATEPrescription
TERBUTALINE SULFATE 2.5MG · TABLET · ORAL

Approval history

2011-04-08Labeling · Supplement 4AP
2005-03-25Original — Other Important Information from FDA ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →